An overview of the current advances in the treatment of inflammatory diseases using mesenchymal stromal cell secretome

References

• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of Guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403.
   PubMedGoogle Scholar
• Berebichez-Fridman R, Montero-Olvera PR. Sources and clinical applications of mesenchymal stem cells: state-of-the-art review. Sultan Qaboos Univ Med J. 2018;18(3):e264–e277.
   PubMedGoogle Scholar
• Rossato C, Brandão WN, Castro SBR, et al. Stem cells from human-exfoliated deciduous teeth reduce tissue-infiltrating inflammatory cells improving clinical signs in experimental autoimmune encephalomyelitis. Biologicals. 2017;49:62–68.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Discher DE, Péault BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. Npj Regen Med. 2019;4(1):1. 2019;4:1–15.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Galipeau J, Krampera M, Barrett J, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016;18(2):151–159.
   PubMed Web of Science ®Google Scholar
• Mohamed-Ahmed S, Fristad I, Lie SA, et al. Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem Cell Res Ther. 2018;9(1):15.
   PubMedGoogle Scholar
• Wiklander OPB, Brennan M, Lötvall J, et al. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. 2019;11(492):eaav8521.
   PubMed Web of Science ®Google Scholar
• Assoni A, Coatti G, Valadares MC, et al. Different donors mesenchymal stromal cells secretomes reveal heterogeneous profile of relevance for therapeutic use. Stem Cells Dev. 2017;26(3):206–214.
   Google Scholar
• Munoz-Perez E, Gonzalez-Pujana A, Igartua M, et al. Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: latest trends in isolation, content optimization and delivery avenues. Pharm0aceutics. 2021;13(11):1802. Vol Page 2021;13:1802.
   PubMed Web of Science ®Google Scholar
• Bhang SH, Lee S, Shin JY, et al. Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis. Mol Ther. 2014;22(4):862–872.
   PubMed Web of Science ®Google Scholar
• Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int. 2014;2014:1–14. 2014.
   Web of Science ®Google Scholar
• Ahangar P, Mills SJ, Cowin AJ. Mesenchymal stem cell secretome as an emerging Cell-Free alternative for improving wound repair. IJMS. 2020;21(19):7038. Vol Page 2020;21:7038.
   Google Scholar
• Kim J, Lee JH, Yeo SM, et al. Stem cell recruitment factors secreted from cord blood-derived stem cells that are not secreted from mature endothelial cells enhance wound healing. In Vitro Cell Dev Biol Anim. 2014;50(2):146–154.
   PubMed Web of Science ®Google Scholar
• Ormazabal V, Nova-Lampeti E, Rojas D, et al. Secretome from human mesenchymal stem cells-derived endothelial cells promotes wound healing in a type-2 diabetes mouse model. IJMS. 2022;23(2):941. Vol Page 2022;23:941.
   Google Scholar
• Wu L, Leijten J, Van Blitterswijk CA, et al. Fibroblast growth factor-1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of osteoarthritic chondrocytes in co-culture. Stem Cells Dev. 2013;22(17):2356–2367.
   PubMed Web of Science ®Google Scholar
• Youssef A, Aboalola D, Han VKM. The roles of insulin-like growth factors in mesenchymal stem cell niche. Stem Cells Int. 2017;2017:1–12.
   Web of Science ®Google Scholar
• Cahill EF, Kennelly H, Carty F, et al. Hepatocyte growth factor is required for mesenchymal stromal cell protection against Bleomycin-Induced pulmonary fibrosis. Stem Cells Transl Med. 2016;5(10):1307–1318.
   PubMed Web of Science ®Google Scholar
• Zagoura DS, Roubelakis MG, Bitsika V, et al. Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. Gut. 2012;61(6):894–906.
   PubMed Web of Science ®Google Scholar
• Cantinieaux D, Quertainmont R, Blacher S, et al. Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One. 2013;8(8):e69515.
   PubMed Web of Science ®Google Scholar
• Kiselevskii MV, Vlasenko RY, Stepanyan NG, et al. Secretome of mesenchymal bone marrow stem cells: is it immunosuppressive or proinflammatory? Bull Exp Biol Med. 2021;172(2):250–253.
   PubMed Web of Science ®Google Scholar
• Wang LT, Wang HH, Chiang HC, et al. Human placental MSC-Secreted IL-1β enhances neutrophil bactericidal functions during hypervirulent Klebsiella infection. Cell Rep. 2020;32(13):108188.
   PubMed Web of Science ®Google Scholar
• Park H. H, Lee S, Yu Y, et al. TGF-β secreted by human umbilical cord blood-derived mesenchymal stem cells ameliorates atopic dermatitis by inhibiting secretion of TNF-α and IgE. Stem Cells. 2020;38(7):904–916.
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol. 2006;177(4):2080–2087.
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu X, Liu L, et al. Transplantation of IFN-γ primed hUCMSCs significantly improved outcomes of experimental autoimmune encephalomyelitis in a mouse model. Neurochem Res. 2020;45(7):1510–1517.
   PubMed Web of Science ®Google Scholar
• Cosenza S, Ruiz M, Toupet K, et al. Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis. Sci Rep. 2017;7(1):1. 2017;7:1–12.
   PubMedGoogle Scholar
• Ooi YY, Dheen ST, Sam Wah Tay S. Paracrine effects of mesenchymal stem Cells-Conditioned medium on microglial cytokines expression and nitric oxide production. Neuroimmunomodulation. 2015;22(4):233–242.
   PubMed Web of Science ®Google Scholar
• Choi H, Lee RH, Bazhanov N, et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood. 2011;118(2):330–338.
   PubMed Web of Science ®Google Scholar
• Guo P, Zhang SZ, He H, et al. TSG-6 controls transcription and activation of matrix metalloproteinase 1 in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2012;53(3):1372–1380.
   PubMed Web of Science ®Google Scholar
• Oh JY, Roddy GW, Choi H, et al. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A. 2010;107(39):16875–16880.
   PubMed Web of Science ®Google Scholar
• Hertsenberg AJ, Shojaati G, Funderburgh ML, et al. Corneal stromal stem cells reduce corneal scarring by mediating neutrophil infiltration after wounding. PLoS One. 2017;12(3):e0171712.
   PubMed Web of Science ®Google Scholar
• Kota DJ, Wiggins LL, Yoon N, et al. TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes. 2013;62(6):2048–2058.
   PubMed Web of Science ®Google Scholar
• Li Q, Song WJ, Ryu MO, et al. TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates severe acute pancreatitis via ER stress downregulation in mice. Stem Cell Res Ther. 2018;9(1):255.
   PubMedGoogle Scholar
• Harrell CR, Jankovic MG, Fellabaum C, et al. Molecular mechanisms responsible for anti-inflammatory and immunosuppressive effects of mesenchymal stem Cell-Derived factors. Adv Exp Med Biol. 2019;1084:187–206.
   PubMed Web of Science ®Google Scholar
• Vishnubhatla I, Corteling R, Stevanato L, et al. The Development of Stem Cell-Derived Exosomes as a Cell-Free Regenerative Medicine. 2014. 3.
   Google Scholar
• Suh N, Subramanyam D, Lee MY. Molecular signatures of secretomes from mesenchymal stem cells: therapeutic benefits. Mol. Cell. Toxicol. 2017;13(2):133–141. 13:2. 2017
   Web of Science ®Google Scholar
• O’Brien J, Hayder H, Zayed Y, et al. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.
   PubMed Web of Science ®Google Scholar
• Dalirfardouei R, Gholoobi A, Vahabian M, et al. Therapeutic role of extracellular vesicles derived from stem cells in cutaneous wound models: a systematic review. Life Sci. 2021;273:119271.
   PubMed Web of Science ®Google Scholar
• Vallabhaneni KC, Penfornis P, Dhule S, et al. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget. 2014;6(7):4953–4967.
   Google Scholar
• Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011;8(5):706–713.
   PubMed Web of Science ®Google Scholar
• Maegdefessel L, Spin JM, Raaz U, et al. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat Commun. 2014;5(1):1–14. 5:1. 2014;5:
   Google Scholar
• Nargesi AA, Lerman LO, Eirin A. Mesenchymal stem cell-derived extracellular vesicles for renal repair. Curr Gene Ther. 2017;17(1):29–42.
   PubMed Web of Science ®Google Scholar
• Bello AB, Kim Y, Park S, et al. Matrilin3/TGFβ3 gelatin microparticles promote chondrogenesis, prevent hypertrophy, and induce paracrine release in MSC spheroid for disc regeneration. Npj Regen Med. 2021;6(1):1–13. 6:1. 2021;6:
   PubMed Web of Science ®Google Scholar
• Alvites R, Branquinho M, Sousa AC, et al. Mesenchymal stem/stromal cells and their paracrine activity—immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics. 2022;14(2):381. Vol Page 2022;14:381.
   PubMed Web of Science ®Google Scholar
• Vizoso FJ, Eiro N, Cid S, et al. Mesenchymal stem cell secretome: toward Cell-Free therapeutic strategies in regenerative medicine. IJMS. 2017;18(9):1852. Vol Page 2017;18:1852.
   Google Scholar
• Beegle J, Lakatos K, Kalomoiris S, et al. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells. 2015;33(6):1818–1828.
   PubMed Web of Science ®Google Scholar
• Kay AG, Treadwell K, Roach P, et al. Therapeutic effects of hypoxic and Pro-Inflammatory priming of mesenchymal stem Cell-Derived extracellular vesicles in inflammatory arthritis. IJMS. 2022;23(1):126.
   Google Scholar
• Hamidian Jahromi S, Li Y, Davies JE. Effect of tumor necrosis factor alpha dose and exposure time on tumor necrosis Factor-Induced gene-6 activation by neonatal and adult mesenchymal stromal cells. Stem Cells Dev. 2018;27(1):44–54.
   PubMed Web of Science ®Google Scholar
• Wang C, Cheng L, Xu H, et al. Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles. Biomaterials. 2012;33(19):4872–4881.
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428(6983):664–668. 2004;428:664–668.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement. Faseb J. 2006;20(6):661–669.
   PubMed Web of Science ®Google Scholar
• Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54–63.
   PubMed Web of Science ®Google Scholar
• Yang H, Tian W, Wang S, et al. TSG-6 secreted by bone marrow mesenchymal stem cells attenuates intervertebral disc degeneration by inhibiting the TLR2/NF-κB signaling pathway. Lab Invest. 2018;98(6):755–772. 2018;98:755–772.
   PubMed Web of Science ®Google Scholar
• Liu L, Song H, Duan H, et al. TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting activations of P38 and JNK signaling. Sci Rep. 2016; 6:30121. 2016;6:1–13.
   PubMed Web of Science ®Google Scholar
• Yang H, Aprecio RM, Zhou X, et al. Therapeutic effect of TSG-6 engineered iPSC-Derived MSCs on experimental periodontitis in rats: a pilot study. PLOS One. 2014;9(6):e100285.
   PubMed Web of Science ®Google Scholar
• Wang G, Cao K, Liu K, et al. Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ. 2018;25(7):1209–1223. 2017;25:1209–1223.
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Kimura A, Nakahama T, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A. 2010;107(46):19961–19966.
   PubMed Web of Science ®Google Scholar
• Kim DS, Jang IK, Lee MW, et al. Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-γ. EBio Medicine. 2018;28:261–273.
   PubMed Web of Science ®Google Scholar
• Prieur AM, Griscelli C, Kaufmann MT, et al. Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet. 1987;2(8570):1240–1242.
   PubMed Web of Science ®Google Scholar
• Fields JK, Günther S, Sundberg EJ. Structural basis of IL-1 family cytokine signaling. Front Immunol. 2019;10:1412.
   PubMed Web of Science ®Google Scholar
• Harrell CR, Markovic BS, Fellabaum C, et al. The role of interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration. Biofactors. 2020;46(2):263–275.
   PubMed Web of Science ®Google Scholar
• Vander Beken S, de Vries JC, Meier-Schiesser B, et al. Newly defined ATP-Binding cassette subfamily B member 5 positive dermal mesenchymal stem cells promote healing of chronic iron-overload wounds via secretion of interleukin-1 receptor antagonist. Stem Cells. 2019;37(8):1057–1074.
   PubMed Web of Science ®Google Scholar
• Kou X, Xu X, Chen C, et al. The fas/fap-1/cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing. Sci Transl Med. 2018;10(432):eaai8524.
   Web of Science ®Google Scholar
• Mohanty ST, Kottam L, Gambardella A, et al. Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther. 2010;12(4):R149–12.
   PubMed Web of Science ®Google Scholar
• Xu AL, Rodriguez LA, Walker KP, et al. Mesenchymal stem cells reconditioned in their own serum exhibit augmented therapeutic properties in the setting of acute respiratory distress syndrome. Stem Cells Transl Med. 2019;8(10):1092–1106.
   PubMed Web of Science ®Google Scholar
• Noh MY, Lim SM, Oh K-W, et al. Mesenchymal stem cells modulate the functional properties of microglia via TGF-β secretion. Stem Cells Transl Med. 2016;5(11):1538–1549.
   PubMed Web of Science ®Google Scholar
• Liu F, Xie J, Zhang X, et al. Overexpressing TGF-β1 in mesenchymal stem cells attenuates organ dysfunction during CLP-induced septic mice by reducing macrophage-driven inflammation. Stem Cell Res Ther. 2020;11(1):1–13.
   PubMed Web of Science ®Google Scholar
• Liu F, Qiu H, Xue M, et al. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the akt/FoxO1 pathway. Stem Cell Res Ther. 2019;10(1):1–14.
   PubMed Web of Science ®Google Scholar
• Lynch K, Treacy O, Chen X, et al. TGF-β1-Licensed murine MSCs show superior therapeutic efficacy in modulating corneal allograft immune rejection in vivo. Mol Ther. 2020;28(9):2023–2043.
   PubMed Web of Science ®Google Scholar
• Xu C, Yu P, Han X, et al. TGF-β promotes immune responses in the presence of mesenchymal stem cells. J Immunol. 2014;192(1):103–109.
   PubMed Web of Science ®Google Scholar
• Ryan JM, Barry F, Murphy JM, et al. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol. 2007;149(2):353–363.
   PubMed Web of Science ®Google Scholar
• de Araújo Farias V, Carrillo-Gálvez AB, Martín F, et al. TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer. Cytokine Growth Factor Rev. 2018;43:25–37.
   PubMed Web of Science ®Google Scholar
• Schaper F, Rose-John S. Interleukin-6: biology, signaling and strategies of blockade. Cytokine Growth Factor Rev. 2015;26(5):475–487.
   PubMed Web of Science ®Google Scholar
• Garbers C, Hermanns HM, Schaper F, et al. Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev. 2012;23(3):85–97.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238. 2006;441:235–238.
   PubMed Web of Science ®Google Scholar
• Chomarat P, Banchereau J, Davoust J, et al. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 2000;1(6):510–514. 2000;1:510–514.
   PubMed Web of Science ®Google Scholar
• Hashizume M, Hayakawa N, Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17. Rheumatology. 2008;47(11):1635–1640.
   PubMed Web of Science ®Google Scholar
• Yasukawa H, Ohishi M, Mori H, et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol. 2003;4(6):551–556.
   PubMed Web of Science ®Google Scholar
• Pullamsetti SS, Seeger W, Savai R. Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension. J Clin Invest. 2018;128(5):1720–1723.
   PubMed Web of Science ®Google Scholar
• MacDonald KPA, Pettit AR, Quinn C, et al. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol. 1999;163(10):5599–5607.
   PubMed Web of Science ®Google Scholar
• Nitahara-Kasahara Y, Kuraoka M, Oda Y, et al. Enhanced cell survival and therapeutic benefits of IL-10-expressing multipotent mesenchymal stromal cells for muscular dystrophy. Stem Cell Res Ther. 2021;12(1):1–15.
   PubMed Web of Science ®Google Scholar
• Choi JJ, Yoo SA, Park SJ, et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol. 2008;153(2):269–276.
   PubMed Web of Science ®Google Scholar
• Wang J, Ren H, Yuan X, et al. Interleukin-10 secreted by mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis. Hepatol Res. 2018;48(3):E194–E202.
   PubMed Web of Science ®Google Scholar
• Bishopric NH. Mesenchymal stem cell-derived IL-10 and recovery from infarction: a third pitch for the chord. Circ Res. 2008;103(2):125–127.
   PubMed Web of Science ®Google Scholar
• Lim JY, Im K. I, Lee ES, et al. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep. 2016; 6:26851. 2016;6:1–13.
   PubMed Web of Science ®Google Scholar
• Anderson P, Souza-Moreira L, Morell M, et al. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 2013;62(8):1131–1141.
   PubMed Web of Science ®Google Scholar
• Legaki E, Roubelakis MG, Theodoropoulos GE, et al. Therapeutic potential of secreted molecules derived from human amniotic fluid mesenchymal stem/stroma cells in a mice model of colitis. Stem Cell Rev Rep. 2016;12(5):604–612.
   PubMed Web of Science ®Google Scholar
• Miranda JP, Camões SP, Gaspar MM, et al. The secretome derived from 3D-cultured umbilical cord tissue MSCS counteracts manifestations typifying rheumatoid arthritis. Front Immunol. 2019;10:18.
   PubMed Web of Science ®Google Scholar
• Uemura R, Xu M, Ahmad N, et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006;98(11):1414–1421.
   PubMed Web of Science ®Google Scholar
• Wei L, Fraser JL, Lu ZY, et al. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012;46(3):635–645.
   PubMed Web of Science ®Google Scholar
• Kong P, Xie X, Li F, et al. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem Biophys Res Commun. 2013;438(2):410–419.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu L, Huo Y, et al. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities. Biomed Res Int. 2014;2014:1–10. 2014
   Web of Science ®Google Scholar
• Jiang CM, Liu J, Zhao JY, et al. Effects of hypoxia on the immunomodulatory properties of human gingiva-derived mesenchymal stem cells. J Dent Res. 2015;94(1):69–77.
   PubMed Web of Science ®Google Scholar
• Pasha Z, Wang Y, Sheikh R, et al. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2007;77(1):134–142.
   PubMed Web of Science ®Google Scholar
• Herrmann JL, Wang Y, Abarbanell AM, et al. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock. 2010;33:24–30.
   PubMed Web of Science ®Google Scholar
• Xu AL, Rodriguez LA, Walker KP, et al. Mesenchymal stem cells reconditioned in their own serum exhibit augmented therapeutic properties in the setting of acute respiratory distress syndrome. Stem cells. Transl Med. 2019;8:1092–1106.
   Google Scholar
• Ghosh D, McGrail DJ, Dawson MR. TGF-β1 pretreatment improves the function of mesenchymal stem cells in the wound bed. Front Cell Dev Biol. 2017;5:28.
   Google Scholar
• Saldaña L, Bensiamar F, Vallés G, et al. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. Stem Cell Res Ther. 2019;10(1):15.
   PubMedGoogle Scholar
• Horie S, Gaynard S, Murphy M, et al. Cytokine pre-activation of cryopreserved xenogeneic-free human mesenchymal stromal cells enhances resolution and repair following ventilator-induced lung injury potentially via a KGF-dependent mechanism. Intensive Care Med Exp. 2020; 8:1. 2020;8:1–15.
   PubMed Web of Science ®Google Scholar
• Eline C, ’, Trouche E, Hél ′ M-H, et al. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells. 2008;26:1749–1757.
   PubMed Web of Science ®Google Scholar
• Tang Y, Cai B, Yuan F, et al. Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant. 2014;23:1279–1291.
   PubMed Web of Science ®Google Scholar
• Wang C-C, Chen C-H, Hwang S-M, et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells. 2009;27:724–732.
   PubMed Web of Science ®Google Scholar
• Dias I, Pinheiro D, Ribeiro Silva K, et al. Secretome effect of adipose tissue-derived stem cells cultured two-dimensionally and three-dimensionally in mice with streptozocin induced type 1 diabetes. CRPHAR. 2021;2:100069.
   Google Scholar
• Tan Y-Z, Cui X, Wang H, et al. The effect of diazoxide on stem cells transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-Sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Tohoku J Exp Med. 2010;220:139–147.
   PubMed Web of Science ®Google Scholar
• Crisostomo PR, Wang Y, Markel TA, et al. Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NFκB- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008;294:675–682.
   PubMed Web of Science ®Google Scholar
• Nagaishi K, Mizue Y, Chikenji T, et al. Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy. Sci Rep. 2017;7(1):8484.
   Web of Science ®Google Scholar
• Zhu Y, Wang Y, Zhao B, et al. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Res Ther. 2017;8(1):8.
   PubMedGoogle Scholar
• Wang Y, Yu D, Liu Z, et al. Exosomes from embryonic mesenchymal stem cells alleviate osteoarthritis through balancing synthesis and degradation of cartilage extracellular matrix. Stem Cell Res Ther. 2017;8(1):1–13.
   PubMed Web of Science ®Google Scholar
• Woo CH, Kim HK, Jung GY, et al. Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration. J Extracell Vesicles. 2020;9(1):1735249.
   PubMed Web of Science ®Google Scholar
• Gupta M, Tieu A, Slobodian M, et al. Preclinical studies of MSC-derived extracellular vesicles to treat or prevent graft versus host disease: a systematic review of the literature. Stem Cell Rev Rep. 2021;17(2):332–340.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439–1441.
   PubMed Web of Science ®Google Scholar
• Wang L, Gu Z, Zhao X, et al. Extracellular vesicles released from human umbilical Cord-Derived mesenchymal stromal cells prevent Life-Threatening acute Graft-Versus-Host disease in a mouse model of allogeneic hematopoietic stem cell transplantation. Stem Cells Dev. 2016;25(24):1874–1883.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yeo RWY, Lai RC, et al. Mesenchymal stromal cell exosome–enhanced regulatory T-cell production through an antigen-presenting cell–mediated pathway. Cytotherapy. 2018;20(5):687–696.
   PubMed Web of Science ®Google Scholar
• Fujii S, Miura Y, Fujishiro A, et al. Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations. Stem Cells. 2018;36(3):434–445.
   PubMed Web of Science ®Google Scholar
• Lai P, Chen X, Guo L, et al. A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD 11 medical and health sciences 1107 immunology. J Hematol Oncol. 2018;11:1–15.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, Xia Y, et al. Therapeutic potential of mesenchymal cell–derived miRNA-150-5p–expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. The. J Immunol. 2018;201(8):2472–2482.
   PubMed Web of Science ®Google Scholar
• Breitman M, Bonfield TL, Caplan AI, et al. Optimization of human mesenchymal stem cells for rheumatoid arthritis: implications for improved therapeutic outcomes. ACR Open Rheumatol. 2022;4(2):152–160.
   PubMedGoogle Scholar
• Kay AG, Long G, Tyler G, et al. Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Sci Rep. 2017;7(1):1–11.
   PubMedGoogle Scholar
• Nazemian V, Manaheji H, Sharifi AM, et al. Long term treatment by mesenchymal stem cells conditioned medium modulates cellular, molecular and behavioral aspects of adjuvant-induced arthritis. Cell Mol Biol (Noisy-le-Grand)). 2018;64(1):19–26.
   PubMed Web of Science ®Google Scholar
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. 11:2. 2011
   PubMed Web of Science ®Google Scholar
• Saheli M, Bayat M, Ganji R, et al. Human mesenchymal stem cells-conditioned medium improves diabetic wound healing mainly through modulating fibroblast behaviors. Arch Dermatol Res. 2020;312(5):325–336.
   PubMed Web of Science ®Google Scholar
• Sharma R, Kumari M, Mishra S, et al. Exosomes secreted by umbilical cord Blood-Derived mesenchymal stem cell attenuate diabetes in mice. J Diabetes Res. 2021;2021:1–15.
   Web of Science ®Google Scholar
• Han S, Mallampalli RK. The acute respiratory distress syndrome: from mechanism to translation. J Immunol. 2015;194(3):855–860.
   PubMed Web of Science ®Google Scholar
• Iglesias M, Butrón P, Torre-Villalvazo I, et al. Mesenchymal stem cells for the compassionate treatment of severe acute respiratory distress syndrome due to COVID 19. Aging Dis. 2021;12(2):360–370.
   PubMed Web of Science ®Google Scholar
• Horie S, Gaynard S, Murphy M, et al. Cytokine pre-activation of cryopreserved xenogeneic-free human mesenchymal stromal cells enhances resolution and repair following ventilator-induced lung injury potentially via a KGF-dependent mechanism. Intensive Care Med Exp. 2020;8(1):8. 2020;8:1–15.
   PubMed Web of Science ®Google Scholar
• Peng W, Chang M, Wu Y, et al. Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway. Stem Cell Res Ther. 2021;12(1):16.
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, et al. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev. 2020;29(12):747–754.
   PubMed Web of Science ®Google Scholar
• Umezawa Y. Psoriatic arthritis. J Dermatol. 2021;48(6):741–749.
   PubMed Web of Science ®Google Scholar
• Attia SS, Rafla M, El-Nefiawy NE, et al. A potential role of mesenchymal stem cells derived from human umbilical cord blood in ameliorating psoriasis-like skin lesion in the rats. Folia Morphol. 2021;81(3):614–631.
   PubMed Web of Science ®Google Scholar
• Yao D, Ye S, He Z, et al. Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trial. Ann Transl Med. 2021;9(22):1653–1653.
   PubMed Web of Science ®Google Scholar
• Seetharaman R, Mahmood A, Kshatriya P, et al. Mesenchymal stem cell conditioned media ameliorate psoriasis vulgaris: a case study. Case Rep Dermatol Med. 2019;2019:1–5.
   Google Scholar
• Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029–0231.
   PubMed Web of Science ®Google Scholar
• Breitbach M, Bostani T, Roell W, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110(4):1362–1369.
   PubMed Web of Science ®Google Scholar
• Yoon YS, Park JS, Tkebuchava T, et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation. 2004;109(25):3154–3157.
   PubMed Web of Science ®Google Scholar
• Műzes G, Sipos F. Mesenchymal stem cell-derived secretome: a potential therapeutic option for autoimmune and immune-mediated inflammatory diseases. Cells. 2022;11(15):2300. Vol Page 2022;11:2300.
   PubMed Web of Science ®Google Scholar
• Burja B, Barlič A, Erman A, et al. Human mesenchymal stromal cells from different tissues exhibit unique responses to different inflammatory stimuli. Curr Res Transl Med. 2020;68(4):217–224.
   PubMed Web of Science ®Google Scholar